Last edition
News about "Phase 1 clinical study"
Sanofi, Regeneron Expand Alliance to Develop Four Long-Acting Antibodies
Sanofi and Regeneron expands their antibody collaboration to develop and commercialise four next-generation long-acting antibodies for immune-mediated diseases.
Phase 1 Clinical Study | 03/10/2026 | By News Bureau | 101
Ascletis Initiates US Phase 1 Study of Oral ASC36 for Obesity
Ascletis has initiated a US Phase 1 study of ASC36, an investigational oral amylin receptor peptide agonist developed using the company’s proprietary oral peptide delivery technology.
Phase 1 Clinical Study | 09/09/2026 | By News Bureau
Alltrna Receives Approval to Begin First-in-Human Trial of tRNA Therapeutic AP003
Alltrna initiates first-in-human trial of engineered tRNA therapy AP003 in Australia, marking a breakthrough in genetic disease treatment.
Phase 1 Clinical Study | 01/04/2026 | By News Bureau | 459
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy